Prevalence and Antimicrobial-Resistant Patterns of Pseudomonas aruginosa among Burn Patients

Zainab Hamid Jassim; Asmaa Taha Yassen; Noor Al-Huda Muthaffar Mahdi; Yasmin Nghemish Mezal; Furgan Ali Hassan; Khaleda Murad  Jihad; Afrah Abd AL-Salam Fadl; Afrah Murtada K adhim

doi:10.52845/CMRO/2025/8-8-1

Zainab Hamid Jassim ⁽¹⁾ , Asmaa Taha Yassen ⁽²⁾ , Noor Al-Huda Muthaffar Mahdi ⁽³⁾ , Yasmin Nghemish Mezal ⁽⁴⁾ , Furgan Ali Hassan ⁽⁵⁾ , Khaleda Murad Jihad ⁽⁶⁾ , Afrah Abd AL-Salam Fadl ⁽⁷⁾ , Afrah Murtada K adhim ⁽⁸⁾

(1) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq. , Iraq

(2) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq. , Iraq

(3) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq. , Iraq

(4) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq , Iraq

(5) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq; , Iraq

(6) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq. , Iraq

(7) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq. , Iraq

(8) Thi-Qar University, College of Science, Department of Pathological Analysis, Iraq. , Iraq

https://doi.org/10.52845/CMRO/2025/8-8-1

Issue
Vol. 8 No. 8 (2025)

Keywords:

Antimicrobial-Resistant, Pseudomonas aruginosa, Burn Patients

PDF

Abstract

Nosocomial infections are a significant global health issue, posing serious public health challenges in hospitals worldwide. The rise of drug-resistant bacteria causing these infections is increasingly problematic, exacerbated by inadequate hygiene practices and routine antimicrobial use, which contribute to heightened antimicrobial resistance. Pseudomonas aeruginosa is common causes of nosocomial infections. Furthermore, antimicrobial resistance is frequently observed in these pathogens, posing significant challenges to treatment. Pseudomonas aeruginosa is one of the commonest organisms causing different infections like wound infections, Lower Respiratory Tract Infection, Urinary tract infection, infections in burn patient in hospital setting. The increasing trend of antibiotic resistance in Pseudomonas aeruginosa poses a challenge to their empiric treatment with conventional agents. So, the objective of this study was to determine the prevalence and antimicrobial resistance pattern of Pseudomonas aeruginosa isolated from different clinical samples.

Full text article

Generated from XML file

References

Al-Kabsi AM, Yusof MYBM, Sekaran SD. Antimicrobial resistance pattern of clinical isolate of Pseudomonas aeruginosa in the University of Malaya Medical Center, Malaysia. African Journal of Microbiology Research. 2011;5(29):5266-72.

Anzai Y, Kim H, Park JY, Wakabaya-shi H, Oyaizu H. Phylogenetic affilia-tion of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol 2000;50:1563-89. [1093 9664]

Barret JP, Herndon DN. Effects of burn wound excision on bacterial colonization and invasion. Plastic and reconstructive surgery. 2003;111(2):744-50. pmid:12560695

Bayram Y, Parlak M, Aypak C, Bayram I. Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey. International journal of medical sciences. 2013;10(1):19. pmid:23289001

Bejarano PA, Langeveld JP, Hudson BG, Noelken ME. Degradation of basement membranes by Pseudo-monas aeruginosa elastase. Infect Immun 1989:57:3783-7. [2509368]

Bendig JW, Kyle PW, Giangrande PL, Samson DM, Azadian BS. Two neutropenic patients with multiple re-sistant Pseudomonas aeruginosa septicaemia treated with ciproflox-acin. JR Soc Med 1987:80:316-7. [3112380]

Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. Indian Journal of Burns. 2015;23(1):56.

Bloemsma G. Dokter J, Boxma H, Oen I. Mortality and causes of death in a burn centre. Burns. 2008;34(8):1103-7. pmid:18538932

Bowen-Jones JR, Coovadia YM, Bowen-Jones EJ. Infection control in a Third World burn facility. Burns 1990:16:445-8. [2073344] [doi: 10.10 16/0305-4179(90)90075-8]

Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. Journal 2014;69(7):1804-14. pmid:24603963 of Antimicrobial Chemotherapy.

Chaudhary NA, Munawar MD, Khan MT, Rehan K, Sadiq A, Bhatti HW, et al. Epidemiology, bacteriological profile, and antibiotic sensitivity pattern of burn wounds in the burn unit of a tertiary care hospital. Cureus. 2019;11(6). pmid:31396464

Chen YC, Ho SW, Luh KT. Persis-tence of a multidrug-resistant Pseu-domonas aeruginosa clone in an in-tensive care burn unit. J Clin Microbiol 1998;36:1347-51. [9574703]

Coetzee E, Rode H, Kahn D. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit. South African Journal of Surgery. 2013;51(2):50-3. pmid:23725892

Deitch EA, Dobke M, Baxter CR. Failure of local immunity. A potential cause of burn wound sepsis. Arch Surg 1985;120:78-84. [3917665]

Deribie A, Mihret A, Demisie Y, Abebe T. Bacteriological profile of burn patients at Yekatit 12 Hospital Burn Center, Ethiopia: A longitudinal study. Ethiopian Journal of Health Development. 2014;28(1):40-4.

Engel J. Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Mi-crobiol. 2009;12:61-6.

Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004;30(4):357-61. pmid:15145194

Felts AG, Giridhar G, Grainger DW, Slunt JB. Efficacy of locally deliv-ered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model. Burns 1999;25:415-23. [10439150] 4179(99)00017-0] [doi:10.1016/S0305-

Franzetti F, Cernuschi M, Esposito R, Moroni M. Pseudomonas infec-tions in patients with AIDS and AIDS related complex. J Intern Med 1992;231:437-43. [1588272]

Godebo GKG, Tassew H. Multidrug-resistant bacterial isolates in infected wounds at Jimma University Specialized Hospital, Ethiopia. Annals of Clinical Microbiology and Antimicrobials. 2013; 12(1):17. pmid:23879886

Goldberg JB, Coyne MJ Jr, Neely AN, Holder IA. A virulence of a Pseudomonas aeruginosa algC mu-tant in a burned-mouse model of in-fection. Infect Immun 1995:63: 4166-9. [7558335]

Guo L, Xu H, Yue Z. Antibiotic resistance pattern of Pseudomonas aeruginosa wound isolates among Chinese burn patients: A systematic review and meta analysis. Asian Pacific Journal of Tropical Medicine. 2022;15(1):17.

Ikpeme EM, Enyi-Idoh KH, Nfongeh JF, Etim LB, Akubuenyi FC. Prevalence, antibiogram profile and cross transmission of Pseudomonas aeruginosa in a tertiary burn unit. Malaysian Journal of Microbiology. 2013:116-9.

Japoni A, Farshad S, Alborzi A, Kalani M, Mohamadzadegan R. Comparison of arbitrarily primed-polymerase chain reaction and plasmid profiles typing of Pseudomonas aeruginosa strains from burn patients and hospital envi-ronment. Saudi Med J 2007:28:899-903. [17530107]

Jung R, Fish D, Obritsch M, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. Journal of Hospital Infection. 2004;57(2):105-11. pmid:15183239

Kalantar E, Taherzadeh S, Ghadimi T, Soheili F, Salimizand H, Hedayatnejad A. Pseudomonas aeruginosa, an emerging pathogen among burn patients in Kurdistan Province, Iran. Southeast Asian Journal of Tropical Medicineand Public Health. 2012;43(3):712. pmid:23077851

Kharazmi A, Nielsen H. Inhibition of human monocyte chemotaxis and chemiluminescence by Pseudomo-nas aeruginosa elastase. APMIS 1991:99:93-5. [1899578]

Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseu-domonas aeruginosa infections inpa-tients with human immunodeficiency virus infection. Clin Infect Dis 1992;14:403-11. [1554824]

Komolafe O, James J, Kalongolera L, Makoka M. Bacteriology of burns at the queen elizabeth central hospital, Blantyre, Malawi. Burns. 2003;29(3):235-8. pmid:12706616

Kumar V, Sen M, Nigam C, Gahlot R, Kumari S. Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2012;16(3):136. pmid:23188953

Kumburu HH, Sonda T, Mmbaga BT, Alifrangis M, Lund O, Kibiki G, et al. Patterns of infections, aetiological agents and antimicrobial resistance at a tertiary care hospital in northern Tanzania. Tropical Medicine & International Health. 2017;22(4):454-64.

Mesaros N, Nordmann P, Plésiat P, Roussel-Delvallez M, Van Eldere J, Głupczynski Y, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clinical microbiology and infection. 2007;13(6):560-78. pmid:17266725

MOAZAMI GS, Eftekhar F. Assessment of carbapenem susceptibility and multidrug-resistance in Pseudomonas aeruginosa burn isolates in Tehran. 2013

Nasser M, Ogali M, Kharat AS. Prevalence of MDR Pseudomonas aeruginosa of war-related wound and burn ward infections from some conflict areas of Western Yemen. Wound medicine. 2018;20:58-61.

Nicas TI, Iglewski BH. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa. Antibiot Chemother 1985:36:40-8. [2988426]

Nouér SA, Nucci M, de-Oliveira MP, Pellegrino FLPC, Moreira BM. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-ẞ-lactamase. Antimicrobial agents and chemotherapy. 2005:49(9):3663-7.

Ostroff RM, Vasil ML. Identification of a new phospholipase C activity by analysis of an insertional mutation in the hemolytic phospholipase C structural gene of Pseudomonas aeruginosa. J Bacteriol 1987; 169:4597-601. [2820937]

Othman N. Babakir-Mina M, Noori CK, Rashid PY. Pseudomonas aeruginosa infection in burn patients in Sulaimaniyah, Iraq: risk factors and antibiotic resistance rates. The Journal of Infection in Developing Countries. 2014;8(11):1498-502. pmid:25390066

Pachori PGR, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes & diseases. 2019; 6(2):109-19.

Paramythiotou E, Routsi C. Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients. World journal of critical care medicine. 2016;5(2):111. pmid:27152254

Pavlovskis OR, Wretlind B. Assess-ment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn in-fection. Infect Immun 1979;24:181-7. [110690]

Phillips LG, Heggers JP, Robson MC, Boertman JA, Meltzer T, Smith DJ Jr. The effect of endogenous skin bacteria on burn wound infection. Ann Plast Surg 1989:23:35-8. [2764460] [doi:10.1097/00000637-198907000-00007]

Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. Common virulence factors for bacterial pathogenicity in plants and animals. Science 1995;268: 1899-902. [76 04262] [doi:10.1126/science. 760 4262]

Raja NS, Singh NN. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. Journal of Microbiology, Immunology, and Infection. 2007;40(1):45–9. pmid:17332906

Rajput A, Saxena R, Singh KP, Kumar V, Singh S, Gupta A, et al. Prevalence and antibiotic resistance pattern of metallo-ẞ-lactamase-producing Pseudomonas aeruginosa from burn patients-experience of an Indian Tertiary Care Hospital. Journal of burn care & research. 2010;31(2):264-8.

Raza MS, Chander A, Ranabhat A. Antimicrobial susceptibility patterns of the bacterial isolates in post-operative wound infections in a tertiary care hospital, Kathmandu, Nepal. Open journal of medical microbiology. 2013;2013

Rezaei E, Safari H, Motamedolshariati SM, Afzal Aghaei M. Analysis of mortality in a burn center. medical journal of mashhad university of medical sciences. 2009;52(4):239-43.

Richcane A, Samuel CT, Pius A, Enoch F, Thomas KG, Poku OSP. Bacteriological profile of burn wound isolates in a burns center of a tertiary hospital. Journal of Acute Disease. 2017;6(4):181.

Rumbaugh KP, Griswold JA, Hamood AN. Contribution of the regulatory gene las to the pathogenesis of Pseudomonas aeruginosa infection of burned mice. J Burn Care Rehabil 1999;20:42-9. [9934636]

Sato H, Okinaga K, Saito H. Role of pili in the pathogenesis of Pseudo-monas aeruginosa burn infection. Microbiol Immunol 1988:32:131-9. [2897617]

Sewunet T, Demissie Y, Mihret A, Abebe T. Bacterial profile and antimicrobial susceptibility pattern of isolates among burn patients at Yekatit 12 hospital burn center, Addis Ababa, Ethiopia. Ethiopian journal of health sciences. 2013;23(3):209-16. pmid:24307820

Sharma G, Rao S, Bansal A, Dang S, Gupta S, Gabrani R. Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals. 2014;42(1):1-7. pmid:24309094

Shrivastava SR, Shrivastava PS, Ramasamy J. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Journal of Medical Society. 2018;32(1):76

Tarashi S. Heidary M. Dabiri H, Nasiri MJ. Prevalence of Drug-resistant Pseudomonas aeruginosa in Iranian Burned Patients: A Meta-analysis. Archives of Trauma Research. 2017:6(3):1-7.

Ullah F, Malik SA, Ahmed J. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan. Burns. 2009;35(7):1020-5. pmid:19501980

Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. Journal of Antimicrobial Chemotherapy. 2003;51(2):347-52. pmid:12562701

Yah S, Eghafona N, Enabulelem I. Prevalence of plasmids mediated pseudomonas aeruginosa resistant genes from burn wound patients at the university of Benin teaching hospital Benin City, Nigeria. 2006.